Red RidgeBio

RedRidge Bio is a clinical-stage biotechnology company that identifies and develops biparatopic antibodies, an antibody class engineered to bind two distinct sites (epitopes) on a single target protein for greater potency and selectivity. Its programs span oncology (antibody-drug conjugates for solid tumors) and autoimmunity (immune-cell modulators), pursued through partnerships and internal discovery. The company operates from Basel, Switzerland with additional presence in Cambridge, Massachusetts and San Francisco. RedRidge Bio was surfaced as a portfolio company of IDG Capital and added to the API Evangelist network. It is a therapeutics developer and publishes no public developer API, SDK, or technical documentation surface at this time; this profile captures its identity and public web presence.

Red RidgeBio is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Biotechnology, Antibodies, and Oncology.

Red RidgeBio’s developer surface includes support and 2 more developer resources.

🌐 Visit website 📡 Source on GitHub
8.4/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyHealthcareBiotechnologyAntibodiesOncologyAutoimmuneDrug DevelopmentTherapeutics

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 8.4/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.9 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/red-ridgebio: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Red Ridgebio Domain Security

TLSv1.3 · HSTS

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support
Support

Company 1

The organization behind the API

Website
Website

Source (apis.yml)

apis.yml Raw ↑ 
aid: red-ridgebio
name: Red RidgeBio
description: RedRidge Bio is a clinical-stage biotechnology company that identifies and develops biparatopic antibodies, an
  antibody class engineered to bind two distinct sites (epitopes) on a single target protein for greater potency and selectivity.
  Its programs span oncology (antibody-drug conjugates for solid tumors) and autoimmunity (immune-cell modulators), pursued
  through partnerships and internal discovery. The company operates from Basel, Switzerland with additional presence in Cambridge,
  Massachusetts and San Francisco. RedRidge Bio was surfaced as a portfolio company of IDG Capital and added to the API Evangelist
  network. It is a therapeutics developer and publishes no public developer API, SDK, or technical documentation surface at
  this time; this profile captures its identity and public web presence.
url: https://raw.githubusercontent.com/api-evangelist/red-ridgebio/refs/heads/main/apis.yml
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://framerusercontent.com/assets/NLXh4ABDKvnllsolRiwyIUG7wvI.jpg
x-type: company
x-source: vc-portfolio
x-backed-by:
- idg-capital
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
x-enrichment:
  date: '2026-07-21'
  status: enriched
  artifacts_added: 1
  pass: local-v1
tags:
- Company
- Healthcare
- Biotechnology
- Antibodies
- Oncology
- Autoimmune
- Drug Development
- Therapeutics
apis: []
common:
- type: DomainSecurity
  url: security/red-ridgebio-domain-security.yml
- type: Website
  url: https://redridgebio.com
- type: Support
  url: mailto:info@redridgebio.com
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io